Le Lézard
Classified in: Health
Subjects: WOM, MAT, DEI

New Sexual Wellness Program Available at Women's Excellence to Help Women Improve Their Sex Life and Treat Intimacy Concerns


The Sexual Wellness Program at Women's Excellence is dedicated to the comprehensive evaluation and treatment of sexual dysfunction.

DETROIT, Aug. 29, 2022 /PRNewswire-PRWeb/ -- Sexual dysfunction can prevent a woman from wanting or enjoying sexual activity. This condition can refer to any phase of normal sexual activity, such as desire, arousal, physical pleasure, or orgasm. As sexual dysfunction can have several causes, it is important to look at a person's overall sexual health to pinpoint the underlying problems. Women's Excellence has designed a comprehensive program designed to improve sexual function for women.

The four main types of sexual dysfunction include:

In women, the most common symptoms include inadequate vaginal lubrication before and during intercourse, inability to relax the vaginal muscles enough for intercourse and/or the inability to achieve orgasm. Sexual dysfunction in women can be managed by identifying the underlying factors and correcting any physical or psychological problems that may be affecting sexual health.

Treatment options at Women's Excellence include:

For more information about Women's Excellence or to schedule an appointment, visit http://www.WomensExcellence.com. Appointments can also be made at (248) 693-0543.

About Women's Excellence
Women's Excellence is the most comprehensive obstetric and gynecological office in Michigan. Additionally, they specialize in menopause, weight control, bladder control, endometriosis, robotic surgery, oncology, and midwifery services. Women's Excellence is committed to staying at the forefront of innovation with cutting edge technologies utilizing robotic surgery and minimally invasive surgical options when possible. The knowledgeable, compassionate physicians and healthcare providers of Women's Excellence focus on patient-centered processes to deliver the highest quality of care. They are affiliated with most insurance. They offer seamless medical record access via a state-of-the-art patient portal and use the latest technology for record keeping and sharing, making the patient's experience easier and more efficient. Women's Excellence is a proud partner of WDVD 96.3 Detroit and WJR 760AM radio, serving as the team of women's health experts for both stations. Women's Excellence is currently accepting new patients and is conveniently located throughout southeastern Michigan in Birmingham, Clarkston, Lake Orion, Lapeer, Royal Oak, and West Bloomfield. For more information, visit http://www.WomensExcellence.com.

Media Contact

Jessica Russette, Women's Excellence in Obstetrics and Gynecology, (248) 693-0543, [email protected]

 

SOURCE Women's Excellence in Obstetrics and Gynecology


These press releases may also interest you

at 05:09
Medical imaging IT and cybersecurity company Sectra (STO: SECT B) is publishing its Annual Report and Sustainability Report for the 2023/2024 fiscal year today. This report also includes the Corporate Governance Report for the same period. The...

at 03:20
Calliditas Therapeutics AB (STO: CALTX) ("Calliditas") today announces that its partner Viatris Pharmaceutical Japan G.K. ("Viatris") has initiated a phase III clinical trial in Japan with Nefecon, named VR-205 in the Japanese market, in Japanese...

at 03:00
Global biotechnology leader CSL Behring today announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at Hemophilia Treatment Centers in France. This milestone achievement makes HEMGENIX® the...

at 02:30
SOPHiA GENETICS , a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced that Dhiti Omics Technologies, a precision molecular diagnostics service provider in India, is live on the SOPHiA...

at 01:15
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the Phase II/III SKYSCRAPER-06 study, evaluating tiragolumab plus Tecentriq® (atezolizumab) and chemotherapy versus pembrolizumab and chemotherapy as an initial...

at 01:05
BenevolentAI ("BenevolentAI" or the "Company") (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery, announces the appointment of Deutsche Numis as the Company's Financial and Capital Markets Adviser,...



News published on and distributed by: